Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE To provide a comprehensive evaluation of chromium (Cr) supplementation on metabolic parameters in a cohort of Type 2 DM subjects representing a wide phenotype range and to evaluate changes in “responders” and “non-responders”. DESIGN After pre-intervention testing to assess glycemia, insulin sensitivity (assessed by euglycemic clamps), Cr status, body composition, subjects were randomized in a double-blind fashion to placebo or 1,000 μg Cr. A sub-study was performed to evaluate 24 hour energy balance/substrate oxidation and myocellular/intra-hepatic lipid content. RESULTS There was not a consistent effect of chromium supplementation to improve insulin action across all phenotypes. Insulin sensitivity was negatively correlated to soleus and tibialis muscle intramyocellular lipids and intra-hepatic lipid content. Myocellular lipids were significantly lower in subjects randomized to Cr. At pre-intervention, “responders”, defined as insulin sensitivity change from baseline > 10%, had significantly lower insulin sensitivity and higher fasting glucose and A1c when compared to placebo and “non-responders”, i.e. insulin sensitivity change from baseline < 10%. Clinical response was significantly correlated (p < 0.001) to the baseline insulin sensitivity, fasting glucose and A1c. There was no difference in Cr status between “responders”, and “non-responders”. CONCLUSIONS Clinical response to chromium is more likely in insulin resistant subjects who have more elevated fasting glucose and A1c levels. Cr may reduce myocellular lipids and enhance insulin sensitivity in subjects with type 2 DM independent of effects on weight or hepatic glucose production. Thus, modulation of lipid metabolism by Cr in peripheral tissues may represent a novel mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flint, A., Raben, A., Blundell, J., & Astrup, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801083 · Cited by 2,238
Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 1×
“To account for day-to-day variation in system performance, peak areas are expressed either relative to the peak area of an external phantom of known constant concentration or relative to an internal water peak assumed to be of constant concentration using the methodology described by Perseghin et al [16] and Krssak et…”
MethodPerseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877
Morino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“and contribute to insulin resistance [18].”
Larson-Meyer, D. E., Heilbronn, L. K., Redman, L. M., Newcomer, B. R., Frisard, M. I., Anton, S., Smith, S. R., Alfonso, A., Ravussin, E., & the Pennington CALERIE Team (2006) · Diabetes Care · doi:10.2337/dc05-2565 · Cited by 504
Self-citationEffect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Nguyen, T., de Jonge, L., Smith, S. R., & Bray, G. A. (2003) · Medical and Biological Engineering and Computing · doi:10.1007/bf02345320 · Cited by 47
Cited by
Role of Minerals and Trace Elements in Diabetes and Insulin Resistance
Dubey, P., Thakur, V., & Chattopadhyay, M. (2020) · Nutrients · doi:10.3390/nu12061864 · Cited by 403
Defining insulin resistance from hyperinsulinemic-euglycemic clamps
Tam, C. S., Xie, W., Johnson, W. D., Cefalu, W. T., Redman, L. M., & Ravussin, E. (2012) · Diabetes Care · doi:10.2337/dc11-2339 · Cited by 364
Self-citationSuksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154
“Cefalu et al.(21) Type 2 DM, FPG ≥ 6 94 mM Age: 30–70 years Body mass index (BMI): 25–40 kg/m(2) / /”
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., & Agarwal, V. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.03.003 · Cited by 120
Tsang, C., Taghizadeh, M., Aghabagheri, E., Asemi, Z., & Jafarnejad, S. (2019) · Clinical Obesity · doi:10.1111/cob.12313 · Cited by 36
Metadata
- Authors
- Cefalu, W. T., Rood, J., Pinsonat, P., Qin, J., Sereda, O., Levitan, L., Anderson, R. A., Zhang, X. H., Martin, J. M., Martin, C. K., Wang, Z. Q., & Newcomer, B.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 59
- Issue
- 5
- Pages
- 755-762
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2152068246
- Cited by
- 115
- References
- 7
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1016/j.metabol.2009.09.023
- The paper
- Cefalu, W. T., Rood, J., Pinsonat, P., Qin, J., Sereda, O., Levitan, L., Anderson, R. A., Zhang, X. H., Martin, J. M., Martin, C. K., Wang, Z. Q., & Newcomer, B. (2010). Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism. https://doi.org/10.1016/j.metabol.2009.09.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.